| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $935.1M | +119.9% |
| Cost of Revenue | $353.4M | +48.8% |
| Gross Profit | $581.7M | +209.9% |
| R&D Expense | $311.7M | +593.1% |
| SG&A Expense | $133.6M | -11.2% |
| Operating Income | $36.2M | +159.5% |
| Interest Expense | $7.2M | -7.3% |
| Pre-tax Income | $26.7M | +135.6% |
| Income Tax | -$1.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $415.7M | +321.9% |
| Accounts Receivable | $213.4M | +138.9% |
| Inventory | $35.5M | +1.0% |
| Current Assets | $677.6M | +187.4% |
| Total Assets | $1.32B | +53.0% |
| Current Liabilities | $247.7M | +173.7% |
| Long-term Debt | $558.1M | +219.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $281.8M | +422.6% |
| Capital Expenditures | $18.3M | +51.1% |
| Investing Cash Flow | -$276.5M | -7608.7% |
| Financing Cash Flow | $311.7M | +892.5% |
| Free Cash Flow | $263.4M | +530.6% |
| +64.1% |
| Net Income | $28.1M | +139.4% |
| EPS (Basic) | $0.41 | +138.7% |
| EPS (Diluted) | $0.40 | +137.7% |
| Total Liabilities |
| $874.1M |
| +118.9% |
| Stockholders' Equity | $447.1M | -3.7% |